WebAug 6, 2024 · It is important to note again that although CDC’s VIS Code Set files are used to convey the codes for EUA Fact Sheets for Recipients and Caregivers, these Fact … Web† Persons with a recent SARS-CoV-2 infection may consider delaying a primary series or booster dose by 3 months from symptom onset or positive test (if infection was asymptomatic). ‡ An 8-week interval between the first and second primary series dose of an mRNA vaccine (ie., Moderna or Pfizer-BioNTech COVID-19 vaccines) may be optimal for ...
Moderna COVID-19 Vaccine - CDC
WebFeb 22, 2024 · Fact Sheets & Other Important Info. ... Updated bivalent booster dose for 12 years of age and older Pfizer-BioNTech COVID-19 Vaccine, Bivalent (Original and Omicron BA.4/BA.5)‡ was designed to help provide protection against COVID-19 caused by the Omicron variant of SARS-CoV-2. Webdoses were given. Please see the Pfizer Fact Sheet or the Moderna Fact Sheet for more information on Updated Booster (bivalent) doses. The previous booster was monovalent and targeted the original strain while the updated boosters are bivalent and target the original strain and the Omicron strains that have been causing the more recent cases. immisoft
FACT SHEET FOR HEALTHCARE PROVIDERS ADMINISTERING …
WebApr 7, 2024 · Moderna’s Vaccine Information Fact Sheets for Recipients and/or Caregivers and Healthcare Providers are available for reference, in addition to a Letter to Healthcare Providers. ... Moderna’s COVID-19 Vaccine, Bivalent booster (ages 6 months – 5 years) be packaged in 2-dose vials in cartons of 10 vials each (20 doses total). Additional ... Webreferred to as Moderna COVID-19 Vaccine, Bivalent. This Fact Sheet pertains only to Moderna COVID-19 Vaccine, Bivalent supplied in a ... For individuals 6 months through 5 years of age, a single booster dose is 0.2 mL. See this Fact Sheet for instructions for preparation and administration. This Fact Sheet may have been updated. For the most ... WebSep 12, 2024 · Evidence supporting use of the Moderna bivalent vaccine is limited to immunogenicity and safety data from the Moderna P205 study at 4 weeks after a second booster (fourth dose). 4,5 Participants aged ≥18 years received Moderna bivalent vaccine as their second booster dose, at least 3 months following a Moderna original primary … immis indian railways